Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter April 18, 2015

17βHSD-3 enzyme deficiency due to novel mutations in the HSD17B3 gene diagnosed in a neonate

  • Elif Sagsak EMAIL logo , Zehra Aycan , Senay Savas-Erdeve , Meliksah Keskin , Semra Cetinkaya and Kadri Karaer

Abstract

17-β-Hydroxysteroid dehydrogenase type 3 (17βHSD-3) is present almost exclusively in the testes, and converts androstenedione (A) to testosterone (T). 17βHSD-3 deficiency is rare. The diagnosis can be missed in early childhood as the clinical presentation may be subtle. The most frequent presentation of 17 HSD-3 deficiency is a 46,XY individual with female external genitalia, labial fusion and a blind ending vagina, with or without clitoromegaly. A low testosterone/androstenedion (T/A) ratio is suggestive of 17βHSD-3 deficiency, and such diagnosis can be confirmed with molecular genetic studies. A 12-day newborn was referred to our hospital because of palpable gonads in the labia majora. On physical examination, the baby had female external genitalia and palpable gonads in the labia majora. T/A ratio was 0.26 and the diagnosis was 17βHSD-3 deficiency, which was confirmed by the evidence of compound heterozygousity novel frameshift mutations in exon 9 and 10 of HSD17B3 gene.


Corresponding author: Elif Sagsak, MD, Dr. Sami Ulus Obstetrics and Gynecology, Children’s Health and Diseases Training and Research Hospital, Pediatric Endocrinology Clinic, Ankara, Turkey, Phone: +90 312 305 65 08, Fax: +90 312 317 03 53, GSM: +90 532 510 2996, E-mail:

References

1. Houk CP, Hughes IA, Ahmed SF, Lee PA. Consensus statement on managment of intersex disorders. J Pediatr Urol 2006;2:148–62.10.1016/j.jpurol.2006.03.004Search in Google Scholar

2. Andersson S,Russell DW, Wilson JD. 17-β-hydroxysteroid dehydrogenase 3 deficiency. Trends Endocrinol Metab 1996;7:121–6.10.1016/1043-2760(96)00034-3Search in Google Scholar

3. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, et al. Male pseudohermaphroditism caused by mutations of testicular 17-β-hydroxysteroid dehydrogenase 3. Nat Genet 1994;7:34–9.10.1038/ng0594-34Search in Google Scholar PubMed

4. Rosler A. 17 beta-hydroxysteroid dehydrogenase3 deficiency in the Mediterranean population. Pediatr Endocrinol Rev 2006;3:455–61.Search in Google Scholar

5. Lee YS, Kirk JM, Stanhope RG, Johnston DI, Harland S, et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol (Oxf) 2007;67:20–28.10.1111/j.1365-2265.2007.02829.xSearch in Google Scholar PubMed

6. Balducci R, Toscano V, Wright F, Bozzolan F, Di Piero G, et al. Familial male pseudohermaphroditism with gynaecomastia due to 17 betahydroxysteroid dehydrogenase deficiency. A report of 3 cases. Clin Endocrinol (Oxf) 1985;23:439–444.10.1111/j.1365-2265.1985.tb01102.xSearch in Google Scholar PubMed

7. Mains LM, Vakili B, Lacassie Y, Andersson S, Lindqvist A, et al. 17betahydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite. Fertil Steril 2008;89:228 e213–e227.10.1016/j.fertnstert.2007.02.048Search in Google Scholar PubMed PubMed Central

8. Rosler A, Silverstein S, Abeliovich D. A (R80Q) mutation in 17 betahydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 1996;81:1827–1831.Search in Google Scholar

9. Neyzi O, Günöz H, Furman A, Bundak R, Gökçay G, et al. Weight, height, head circumference and body mass index references for Turkish children. Çocuk Sağlığı ve Hastalıkları Dergisi 2008;51:1–14.Search in Google Scholar

10. Ayfer Alikasiroglu, Olaf Hiort, Nazli Gonc, Huseyin Demirbilek, Emregul lsik, et al. 17p-Hydroxysteroid dehydrogenase type 3 deficiency as a result of a homozygous 7 base pair deletion in 17βHSD3 gene. J Pedialr Endocr Met 2012;25:561–563.Search in Google Scholar

11. George MM, New MI, Ten S, Sultan C, Bhangoo A. The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency. Horm Res Paediatr 2010;74:229–40.10.1159/000318004Search in Google Scholar PubMed

12. Bertelloni S, Dati E, Hiort O. Diagnosis of 17 beta-hydroxysteroid dehydrogenase deficiency. Expert Rev Endocrinol Metab 2009;4:53–65.10.1586/17446651.4.1.53Search in Google Scholar

13. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, et al. Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 1996;81:130–136.Search in Google Scholar

14. Mendonca BB, Inacio M, Arnhold IJ, Costa EM, Bloise W, et al. Male pseudohermaphroditism due to 17 beta- hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine(Baltimore) 2000;79:299–309.Search in Google Scholar

Received: 2014-8-22
Accepted: 2015-3-6
Published Online: 2015-4-18
Published in Print: 2015-7-1

©2015 by De Gruyter

Downloaded on 9.12.2023 from https://www.degruyter.com/document/doi/10.1515/jpem-2014-0354/html
Scroll to top button